“…Congenital metabolic disorders and obesity can result from Mendelian mutations in transcription factors that control hypothalamic patterning (Blanchet et al, 2017;Holder et al, 2000), and mutations in genes identified as important for controlling hypothalamic and neurogenesis in this study may contribute to multigenic disorders that may have a hypothalamic origin, such as Type 2 diabetes, sleep disorders, and depression (Bao et al, 2008;Biran et al, 2015;Dearden and Ozanne, 2015). Understanding the molecular mechanisms controlling early hypothalamic development is also critical to efforts towards induced differentiation of specific hypothalamic neuronal subtypes from embryonic stem (ES) or induced pluripotent stem (iPS) cells (Merkle et al, 2015;Nagasaki et al, 2015;Seifinejad et al, 2019;Wang et al, 2016), as well as for directed reprogramming of hypothalamic glial cells (Kano et al, 2019;Yoo et al, 2021). Cell-based approaches such as these may ultimately hold the potential for the directed rewiring of core hypothalamic regulatory circuitry for treating a broad range of homeostatic disorders.…”